m+Medelevator.RU
← Поиск публикаций
Methods (San Diego, Calif.) · 2026

A fluorescence-based high-content imaging workflow for multi-parametric lipid droplet phenotyping via Oil Red O fluorescence.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Yan Shaojun, Yao Yuqin, Liu Congying, Zhu Hui, Wu Xiaoyan, Lyu Chunming, Yang Yang

Аннотация

UNLABELLED: Progression of Metabolic-associated Fatty Liver Disease (MAFLD) involves excessive accumulation of intrahepatic lipid droplets (LDs). However, cost-effective, high-throughput imaging for detailed, multi-parametric LDs quantification at the single-cell level remains difficult.

MATERIALS AND METHODS: Here, we established a high-content screening (HCS) platform that utilizes the fluorescence of Oil Red O (ORO) to quantify LD phenotypes. This method enables the simultaneous extraction of multi-parametric morphological features, including LD number, size, intensity, and spatial dispersion, in free fatty acid (FFA)-induced AML12 hepatocytes. As a proof-of-concept, we systematically screened and validated a library of 36 lipid-lowering compounds derived from the literature.

RESULTS: The ORO fluorescence-based HCS platform demonstrated adequate sensitivity, low background interference, and spatial resolution for single-cell quantification compared to bright-field analysis. Data clustering classified monomeric compounds into distinct lipid-regulatory patterns. For instance, pentacyclic triterpenoids decreased the number and size of LDs, while diterpene quinones reduced LD density.

CONCLUSION: This study establishes a credible, visualizable, and economical HCS approach for assessing LD dynamics. By correlating multidimensional imaging metrics with specific cellular phenotypes, this platform provides a practical method for evaluating lipotoxicity and for high-throughput discovery of anti-steatotic drug candidates from natural product libraries.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты